The bioindustrial revolution is here, and at its cutting edge are life-saving cell therapies and innovative cell-based products.

We are asking the hard question: how do we remove the manufacturing barriers preventing mass-market entry for these innovations? ‍

We believe building automated, smart machines that can linearly scale manufacturing capacity to flexibly meet demand will achieve this goal.

The industries we serve are the new pillars of the $2T+ bioeconomy and will be instrumental in improving human and planetary health.‍